Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

'England, the English and the problem of education in South Africa.’

2013-09-26

Attending the lecture were, from the left: Dr Susan Brokensha, Senior Lecturer: Department of English; Prof Rosemary Gray, Professor Emeritus (Honorary Life Vice-President of the English Academy of Southern Africa); Prof Jonathan Jansen; and Dr Thinus Conradie, Lecturer: Department of English.
Photo: Johan Roux
26 September 2013

Prof Jonathan Jansen: Lecture

The university celebrated the life of one of South Africa's most renowned art critics, hosting the 2013 English Academy’s Percy Baneshik Memorial Lecture on the Bloemfontein Campus.

The keynote lecture was delivered by Prof Jonathan Jansen, Vice-Chancellor and Rector, who joined a distinguished list of speakers to have delivered the lecture. Presented annually by the English Academy of Southern Africa, an association dedicated to promoting the effective use of English as a dynamic language in Southern Africa, past speakers include Prof Es’kia Mphahlele, Prof Njabulo Ndebele, Dr Alan Paton and Prof Albie Sachs. The lecture is hosted at venues across the country and this year Bloemfontein paid tribute to Percy Baneshik.

In his speech Not even colonial born: England, the English and the problem of education in South Africa,' Prof Jansen addressed the dilemma of the politics of language in both school and university education today.

Talking about the dominance of English in schools, Prof Jansen said it is the language of choice because indigenous languages are so poorly taught. "Simply learning in your mother tongue is absolutely no guarantee of improved learning gains in school. The problem is not the language of instruction; it is the quality of teaching, the knowledge of curriculum and the stability of the school."

Prof Jansen told the audience in the CR Swart Hall that Afrikaans-exclusive, or even Afrikaans-dominant white schools represent a serious threat to race relations in South Africa. "You simply cannot prepare young people for dealing with the scars of our violent past without creating optimal opportunities in the educational environment for living and learning together."

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept